Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy-negative individuals
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
The mRNA for the Duffy blood group antigen, the erythrocyte receptor for the Plasmodium vivax malaria parasite, has recently been cloned and shown to encode a widely expressed chemokine receptor. Here, we show that the Duffy antigen/chemokine receptor gene (DARC) is composed of a single exon and that most Duffy-negative blacks carry a silent FY*B allele with a single T to C substitution at nucleotide -46. This mutation impairs the promoter activity in erythroid cells by disrupting a binding site for the GATA1 erythroid transcription factor. With the recent characterization of the FY*A and FY*B alleles, these findings provide the molecular basis of the Duffy blood group system and an explanation for the erythroid-specific repression of the DARC gene in Duffy-negative individuals.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“DARC is an atypical chemokine receptor and the antigen of the Duffy (Fy) blood group system (Tournamille et al., 1995; Tournamille et al., 1998; Wasniowska and Hadley, 1994).”
From Staphylococcus aureus Targets the Duffy Antigen Receptor for Chemokines (DARC) to Lyse Erythrocytes (2015) · cites this paper as Tournamille et al., 1995
In the citing paper
“A substantial part of the human population carries a homozygous mutation (FY*AES or FY*BES alleles for erythrocyte silent) in the erythroid-specific promoter of the FY gene, resulting in a lack of expression of the receptor on erythrocytes (Fya−/b− phenotype) but not in non-erythroid tissues (Tournamille et al., 1995; Zimmerman et al., 1999).”
From Staphylococcus aureus Targets the Duffy Antigen Receptor for Chemokines (DARC) to Lyse Erythrocytes (2015) · cites this paper as Tournamille et al., 1995
Citations
Cites
Luckow, B., & Schütz, G. (1987) · Nucleic Acids Research · doi:10.1093/nar/15.13.5490 · Cited by 1,701
MODEL SYSTEMS FOR THE STUDY OF SEVEN-TRANSMEMBRANE-SEGMENT RECEPTORS
Dohlman, H. G., Thorner, J., Caron, M. G., & Lefkowitz, R. J. (1991) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.60.070191.003253 · Cited by 1,379
The Resistance Factor to Plasmodium vivax in Blacks: The Duffy-Blood-Group Genotype,FyFy
Miller, L. H., Mason, S. J., Clyde, D. F., & McGinniss, M. H. (1976) · New England Journal of Medicine · doi:10.1056/nejm197608052950602 · Cited by 1,260
Race, R. R., & Sanger, R. A. (1962) · Medical Entomology and Zoology · Cited by 1,162
Compilation of vertebrate-encoded transcription factors
Faisst, S., & Meyer, S. (1992) · Nucleic Acids Research · doi:10.1093/nar/20.1.3 · Cited by 914
GATA-binding transcription factors in hematopoietic cells
Orkin, S. (1992) · Blood · doi:10.1182/blood.v80.3.575.575 · Cited by 884
Erythrocyte Receptors for ( Plasmodium Knowlesi ) Malaria: Duffy Blood Group Determinants
Miller, L. H., Mason, S. J., Dvorak, J. A., McGinniss, M. H., & Rothman, I. K. (1975) · Science · doi:10.1126/science.1145213 · Cited by 610
Red blood cells are a sink for interleukin 8, a leukocyte chemotaxin.
Darbonne, W. C., Rice, G. C., Mohler, M. A., Apple, T., Hébert, C. A., Valente, A. J., & Baker, J. B. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115442 · Cited by 452
Globin gene regulation and switching: Circa 1990
Orkin, S. H. (1990) · Cell · doi:10.1016/0092-8674(90)90133-y · Cited by 442
Chitnis, C. E., & Miller, L. H. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.2.497 · Cited by 426
Research works printed but not linked: 1
- Toumamilte, C., Le Van Kim, C., Gane, P., Cartron, J.P. & Colin, Y. Molecular basis and PCR-DNA typing of the Pya/Pyb blood group polymorphism. Hum. Genet. 85, 407–410 (1995).
Cited by
Items 401–500 of 742
de Oliveira, H. S. S., Silva, A. N. L. M. D., Andrade, G. B., Gaia, K. C., Costa, G. D. L. C., Ribeiro‐dos‐Santos, Â., & Guerreiro, J. F. (2018) · Genetics and Molecular Biology · doi:10.1590/1678-4685-gmb-2017-0253 · Cited by 17
Ali, R. K. A., Dhyani, A., Terço, A. L., Toro, D. M., Gomes, K. S., Tezza, L. C., Negreiros, M. A., Batista, C. S., Souza, M. K. S., Sanguino, E. C. B., et al. (2019) · Malaria Journal · doi:10.1186/s12936-019-2918-4 · Cited by 15
Phylogenetic Modeling of Regulatory Element Turnover Based on Epigenomic Data
Dukler, N., Huang, Y.-F., & Siepel, A. C. (2020) · Molecular Biology and Evolution · doi:10.1093/molbev/msaa073 · Cited by 17
Sequence-Based Typing of Human Blood Groups
Seltsam, A. W., & Doescher, A. (2009) · Transfusion Medicine and Hemotherapy · doi:10.1159/000217322 · Cited by 15
A polymorphic dinucleotide repeat in the human dopamine D5 receptor gene promoter
Beischlag, T. V., Nam, D., Ulpian, C., Seeman, P. M., & Niznik, H. B. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(96)12416-2 · Cited by 15
Chaudhuri, A., Yuen, G. S., Fang, F., & Storry, J. R. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.05208.x · Cited by 15
“This substitution impairs promoter activity in erythroid cells by disrupting the binding site for the GATA1 protein (Tournamille et al, 1995).”
BackgroundResultRegulation of Motor Function and Behavior by Atypical Chemokine Receptor 1
Schneider, E. H., Fowler, S. C., Lionakis, M. S., Swamydas, M., Holmes, G., Diaz, V., Munasinghe, J., Peiper, S. C., Gao, J., & Murphy, P. M. (2014) · Behavior Genetics · doi:10.1007/s10519-014-9665-7 · Cited by 16
“In addition, in humans, erythrocyte ACKR1 is exploited for cell entry by Plasmodium vivax, a major cause of malaria, and red blood cell selective ACKR1negative individuals with a mutation in the ACKR1 promoter are protected from this disease (Miller et al. 1976; Tournamille et al. 1995).”
Woolley, I. J., Wood, E. M., Sramkoski, R. M., Zimmerman, P. A., Miller, J. P., & Kazura, J. W. (2005) · Immunohematology · doi:10.21307/immunohematology-2019-387 · Cited by 14
“Subsequently, it has been shown that this phenotype, which expresses neither Duffy antigen receptor for chemokines (DARC) mRNA nor protein, is caused by a nucleotide polymorphism in the GATA-1 binding site of the promoter regions: a single T to C substitution at nucleotide -46.(3) This change in the promoter region pr…”
BackgroundGenetic Regulation of Malaria Infection in Humans
Troye‐Blomberg, M. (2002) · KARGER eBooks · doi:10.1159/000058847 · Cited by 15
Application of DNA analysis to the quality assurance of reagent red blood cells
Storry, J. R., Olsson, M. L., & Reid, M. E. (2007) · Transfusion · doi:10.1111/j.1537-2995.2007.01315.x · Cited by 15
“The mutation is erythroid-specific so that RBCs of individuals with this mutation lack the Fy glycoprotein.(12) In central and west Africa, the Fy(a–b–) phenotype is highly prevalent, up to 100 percent in some regions.”
BackgroundMullighan, C. G., Marshall, S. E., Fanning, G. C., Briggs, D., & Welsh, K. I. (1998) · Tissue Antigens · doi:10.1111/j.1399-0039.1998.tb02964.x · Cited by 15
A model for integrating molecular-based testing in transfusion services.
Sandler, S. G., Horn, T., Keller, J. A., Langeberg, A., & Keller, M. A. (2016) · Europe PMC (PubMed Central) · doi:10.2450/2015.0070-15 · Cited by 14
Zhao, Y. C., Tang, L., Li, Z., Jin, J., Luo, J., & Gao, G. (2015) · BMC Evolutionary Biology · doi:10.1186/s12862-015-0345-x · Cited by 17
“immune responses [1] and pathogen interactions [5,6] in humans, the origin of a partially reproductively isolated race in Drosophila melanogaster [7,8], and the”
Backgroundde Carvalho, T. L. G., Ribolla, P. E. M., Curi, R. A., & da Mota, L. S. L. S. (2009) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2009.05.016 · Cited by 15
“The phenotype Fy(a b ) in black Africans is due to a point mutation 33 T > C in the promoter region of allele FY*B, in the GATA box region (Tournamille et al., 1995; Iwamoto et al., 1996).”
BackgroundInfluentialDNA-based assays for patient testing: their application, interpretation, and correlation of results
Lomas, C., & DePalma, H. (2008) · Immunohematology · doi:10.21307/immunohematology-2019-296 · Cited by 14
Fennell, K. A., Hoffman, R., Yoshida, K., Iwamoto, S., Govender, L., Vather, K., Sookraj, A., Jentsch, U., Pambrun, C., McAuley, C., et al. (2017) · Transfusion · doi:10.1111/trf.14299 · Cited by 15
“On the other hand, two GATA motif variants have been reported in the FY promoter and found to abrogate the expression of Fy or Fy antigens.(6-8) Two GATA motif variants have also been reported in the ABO Intron 1 enhancer element, associated with decreased expression of A and B antigens(9-11) and shown to reduce the e…”
BackgroundSrivastava, K., Khil, P. P., Sippert, E., Volkova, E., Dekker, J. P., Rios, M., & Flegel, W. A. (2020) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2020.06.014 · Cited by 17
Stone, E. F., Avecilla, S. T., Wuest, D. L., Lomas, C., Westhoff, C. M., Diuguid, D. L., Sadelain, M., Boulad, F., & Shi, P. A. (2020) · Haematologica · doi:10.3324/haematol.2020.253229 · Cited by 14
“The absence of FY protein on the RBCs is primarily due to a point mutation in the GATA promotor region on a FYB allele such that the erythroid transcription factor GATA-1 fails to bind (12); thus, RBCs lack expression of Fy (3).”
BackgroundBorinstein, S. C., Agamasu, D., Schildcrout, J. S., Bastarache, L. A., Bagheri, M., Davis, L. K., Roden, D. M., Stein, C., Driest, S. L. V., & Mosley, J. D. (2022) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17346 · Cited by 13
Multiple interests in structural models of DARC transmembrane protein
Smolarek, D., Bertrand, O., Czerwiński, M., Colin, Y., Etchebest, C., & de Brevern, A. G. (2010) · Transfusion Clinique et Biologique · doi:10.1016/j.tracli.2010.05.003 · Cited by 14
“The Duffy negative phenotype of WAAP red cells (noted Fy(a-b-)) is due to homozygosity for a promoter polymorphism (46C) in which the binding site for the transcription factor (GATA-1), required for DARC to be expressed on the cell surface of erythrocytes [10], is disrupted.”
BackgroundSelf-citationApproaches to the identification of susceptibility genes
Collins, A. R. (2009) · Parasite Immunology · doi:10.1111/j.1365-3024.2008.01089.x · Cited by 17
High frequency of the Duffy-negative genotype and absence of Plasmodium vivax infections in Ghana
Brown, C. A., Pappoe-Ashong, P. J., Duah-Quashie, N. O., Ghansah, A., Asmah, H., Afari, E. A., & Koram, K. A. (2021) · Malaria Journal · doi:10.1186/s12936-021-03618-0 · Cited by 14
Cancer microenvironment and genomics: evolution in process
Leong, S. P. L., Witz, I. P., Sagi‐Assif, O., Izraely, S., Sleeman, J. P., Piening, B., Fox, B. A., Bifulco, C. B., Martini, R. N., Newman, L. A., et al. (2021) · Clinical & Experimental Metastasis · doi:10.1007/s10585-021-10097-9 · Cited by 17
“We know that Duffy-null is a promoter region variant of the Duffy Antigen Receptor for Chemokines/Atypical Chemokine Receptor 1 gene (DARC/ ACKR1) and removes its expression from red blood cells (RBCs) specifically [100].”
BackgroundMazières, S., Temori, S. A., Vasseur, H., Gallian, P., Cristofaro, J. D., & Chiaroni, J. (2013) · Transfusion Medicine · doi:10.1111/tme.12038 · Cited by 14
Cockburn, I. A., & Rowe, J. A. (2005) · International Journal of Immunogenetics · doi:10.1111/j.1744-313x.2005.00552.x · Cited by 14
“The Duffy-negative phenotype occurs because of a mutation in a GATA1 binding site at nucleotide −46 of the Duffy antigen/chemokine receptor gene (Tournamille et al., 1995).”
BackgroundMinisequencing‐Based Genotyping of Duffy and ABO Blood Groups for Forensic Purposes
Ferri, G., Bini, C., Ceccardi, S., Ingravallo, F., Lugaresi, F., & Pelotti, S. (2006) · Journal of Forensic Sciences · doi:10.1111/j.1556-4029.2006.00058.x · Cited by 14
“This SNP disrupts the binding site for the GATA-1 erythroid transcription factor, resulting in a silent FY B in the erythroid lineage but not in other tissues (5).”
BackgroundIndividual variation in Plasmodium vivax malaria risk: Are repeatedly infected people just unlucky?
Corder, R. M., Arez, A. P., & Ferreira, M. U. (2023) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0011020 · Cited by 14
“vivax infection is a T!C nucleotide substitution in the erythrocyte-specific GATA1 transcription factor–binding motif, which abolishes DARC expression on RBCs [46].”
BackgroundInfluentialBradley, L., Yewhalaw, D., Hemming‐Schroeder, E., Jeang, B., Lee, M., Zemene, E., Degefa, T., Lo, E. Y. Y., King, C. L., Kazura, J. W., et al. (2024) · Malaria Journal · doi:10.1186/s12936-024-04895-1 · Cited by 15
“…genotype data of the T33C point mutation in the promoter region of the GATA-1 transcription factor binding site of the Duffy antigen receptor for chemokines (DARC) gene, which is known to alter erythroid expression and eliminate Duffy antigen expression on the red blood cell surface [30, 31, 46].”
BackgroundOchola‐Oyier, L. I., Wamae, K., Omedo, I., Ogola, C. A., Matharu, A. K., Musabyimana, J. P., Njogu, F. K., & Marsh, K. (2019) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2019.02.004 · Cited by 11
“At codon 42, all the 91 samples sequenced coded for the amino acid aspartate, thus the entire population sampled expressed the FY*B allele, which confirms previous findings that most people of African descent carry the erythrocyte silent FY*B ancestral allele (Miller et al., 1976; Tournamille et al., 1995).”
ResultAssociation between Rhesus Blood Groups and Malaria Infection: A Systematic Review and Meta-Analysis
Rattanapan, Y., Duangchan, T., Wangdi, K., Mahittikorn, A., & Kotepui, M. (2023) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed8040190 · Cited by 14
“Fy(a−b−), results from a mutation in the GATA-1 of the promoter region of the DARC gene [60].”
BackgroundWu, P. C., Lee, Y. Q., Möller, M., Storry, J. R., & Olsson, M. L. (2023) · Nature Communications · doi:10.1038/s41467-023-40708-w · Cited by 13
“…molecular basis of the interindividual variation in RBC expression levels observed for most blood groups is unknown, although genotype/phenotype discrepancies in the ABO and FY systems resulted in the discovery of SNVsaffecting GATA1-bindingsites crucialforRBCexpressionofthese blood groups 1,2 .”
InfluentialPlasmodium vivax in Sub-Saharan Africa: An Advancing Threat to Malaria Elimination?
Oboh, M. A., & Zimmerman, P. A. (2023) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.23-0523 · Cited by 16
Parolín, M. L., Avena, S. A., Fleischer, S., Pretell, M., Rocca, F. D. F., Rodríguez, D. A., Dejean, C. B., Postillone, M. B., Vaccaro, M. S., Dahinten, S. L., et al. (2013) · Revista Argentina de Antropología Biológica · Cited by 20
Insights into the invasion biology of Plasmodium vivax
Prajapati, S. K., & Singh, O. P. (2013) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2013.00008 · Cited by 13
“The Duffy negative trait is conferred by a point mutation in the promoter region of the Duffy receptor gene, which abolishes erythroid expression of this receptor (Tournamille et al., 1995).”
BackgroundMalaria in antiquity: a genetics perspective
Hume, J. C. C. (2003) · World Archaeology · doi:10.1080/0043824032000111362 · Cited by 18
“Duffy negativity is a homozygous recessive trait caused by an SNP in the promoter region of the DARC gene that removes the Duffy receptor from erythrocytes only (Tournamille et al. 1995: 224–8).”
BackgroundRoche, B., Rougeron, V., Quintana‐Murci, L., Renaud, F., Abbate, J. L., & Prugnolle, F. (2016) · Trends in Parasitology · doi:10.1016/j.pt.2016.09.010 · Cited by 13
Ansart‐Pirenne, H., Martin‐Blanc, S., Pennec, P. Y. L., Rouger, P., Cartron, J., & Tournamille, C. (2006) · Vox Sanguinis · doi:10.1111/j.1423-0410.2006.00872.x · Cited by 14
Self-citationEstalote, A. C., Proto‐Siqueira, R., Silva, W. A., Zago, M. A., & Palatnik, M. (2005) · PubMed · Cited by 13
Kim, C. L. V., Tournamille, C., Kroviarski, Y., Cartron, J., & Colin, Y. (1997) · Blood · doi:10.1182/blood.v90.7.2851.2851_2851_2853 · Cited by 13
Self-citationDaniels, G. L. (2013) · Wiley eBooks · doi:10.1002/9781118520093.ch3 · Cited by 13
Tang, T., Owen, J. D., Du, J., Walker, C. L., & Richmond, A. (1998) · DNA sequence · doi:10.3109/10425179809072188 · Cited by 13
The monogenic landscape of human infectious diseases
Boisson‐Dupuis, S., Bastard, P., Béziat, V., Bustamante, J. C., Cobat, A., Jouanguy, E., Puel, A., Rosain, J., Zhang, Q., Zhang, S., et al. (2024) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2024.12.1078 · Cited by 12
Miri‐Moghaddam, E., Bameri, Z., & Mohamadi, M. (2014) · Asian Pacific Journal of Tropical Medicine · doi:10.1016/s1995-7645(14)60021-3 · Cited by 12
Liu, Z., Yang, J., Xu, H., Li, C., Wang, Z., Li, Y., Dong, X., & Li, Y. (2014) · Genetic Epidemiology · doi:10.1002/gepi.21846 · Cited by 16
“Variation in gene expression is thought to make a significant contribution to phenotypic diversity among individuals and species [Chan et al., 2010; Tournamille et al., 1995].”
BackgroundHuman Expression QTLs Are Enriched in Signals of Environmental Adaptation
Ye, K., Lü, J., Raj, S. M., & Gu, Z. (2013) · Genome Biology and Evolution · doi:10.1093/gbe/evt124 · Cited by 15
“…of a regulatory mutation in the promoter of DARC in the subSaharan African populations, which abolishes the expression of DARC in erythrocytes and benefits its homozygous carriers with complete resistance to malarial parasites, Plasmodium vivax (Tournamille et al. 1995; Hamblin and Di Rienzo 2000).”
BackgroundEcological Developmental Biology: Interpreting Developmental Signs
Gilbert, S. F. (2016) · Biosemiotics · doi:10.1007/s12304-016-9257-4 · Cited by 14
“But the protein remains on the surfaces of neurons and capillaries (Tournamille et al. 1995).”
BackgroundAllen, E. S., Nelson, R. C., & Flegel, W. A. (2018) · Transfusion · doi:10.1111/trf.14871 · Cited by 12
Acute hemolytic transfusion reaction secondary to anti-Fy3
Olteanu, H., Gerber, D. E., Partridge, K., & Sarode, R. (2005) · Immunohematology · doi:10.21307/immunohematology-2019-392 · Cited by 12
“She was transfused with two units of RBCs.”
BackgroundInfluentialGenetics and the general physician: insights, applications and future challenges
Knight, J. C. (2009) · QJM · doi:10.1093/qjmed/hcp115 · Cited by 16
“This failure of expression is the result of a T to C nucleotide substitution in the regulatory sequence (the promoter region) found upstream of the DARC gene which disrupts the binding of the transcription factor GATA-1, a protein which binds DNA and helps regulate gene expression (Figure 3).(66) Consideration of thes…”
BackgroundAraújo, F., Pereira, C. C., Alexio, A., Enriques, I. H., Monteiro, F., Meireles, E., Lacerda, P., & Cunha-Ribeiro, L. M. (2001) · Immunohematology · doi:10.21307/immunohematology-2019-542 · Cited by 12
McGowan, E. C., Wu, P. C., Hellberg, Å., Lopez, G. H., Hyland, C. A., & Olsson, M. L. (2024) · Transfusion Medicine and Hemotherapy · doi:10.1159/000538469 · Cited by 12
“The fi rst example was reported in the FY system nearly 3 decades ago, where the serologically Duffy-negative phenotype on RBCs was shown to be due to a disruption in a GATA1-binding motif located in the ACKR1 (then DARC ) gene promoter [26].”
BackgroundEvolutionary Medicine, Immunity, and Infectious Disease
Muehlenbein, M. P. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511781193.034 · Cited by 16
Hyperhemolytic transfusion reaction attributable to anti-Fy3 in a patient with sickle cell disease
Reyes, M. A., & Illoh, O. (2008) · Immunohematology · doi:10.21307/immunohematology-2019-263 · Cited by 11
The Malaria-High Blood Pressure Hypothesis: Revisited
Nwokocha, C. R., Bafor, E. E., Ajayi, O. I., & Ebeigbe, A. B. (2020) · American Journal of Hypertension · doi:10.1093/ajh/hpaa051 · Cited by 11
Abebe, A., Bouyssou, I., Mabilotte, S., Dugassa, S., Assefa, A., Juliano, J. J., Lo, E. Y. Y., Ménard, D., & Golassa, L. (2023) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0011326 · Cited by 11
Molecular DNA ‐based testing for blood group antigens: recipient–donor focus
Westhoff, C. M. (2013) · ISBT Science Series · doi:10.1111/voxs.12049 · Cited by 11
Martins, M. L., da Silva, A. R., Santos, H. C., Alves, M. T., Schmidt, L. C., Vertchenko, S. B., Dusse, L. M. S., & Malta, M. C. F. D. S. (2017) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2017.06.001 · Cited by 11
Chapter 9 The Duffy Antigen Receptor for Chemokines
Rot, A., & Horuk, R. (2009) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(09)05409-3 · Cited by 11
Red cell polymorphisms and malaria: an evolutionary approach
Bauduer, F. (2012) · Bulletins et Mémoires de la Société d anthropologie de Paris · doi:10.1007/s13219-012-0060-8 · Cited by 15
Sistema de grupo sangüíneo Duffy: biologia e prática transfusional
Jens, E., Pagliarini, T., & Novaretti, M. C. Z. (2005) · Revista Brasileira de Hematologia e Hemoterapia · doi:10.1590/s1516-84842005000200011 · Cited by 11
Martincic, I., Mastronardi, C., Chung, A., & Ramírez‐Arcos, S. (2008) · Immunohematology · doi:10.21307/immunohematology-2019-262 · Cited by 11
Genes Influencing Susceptibility to Infection
Petri, W. A., Kirkpatrick, B. D., Haque, R., & Duggal, P. (2007) · The Journal of Infectious Diseases · doi:10.1086/524118 · Cited by 11
“[3], the 32-bp deletion in the CCR5 che-”
BackgroundOrigin of the New World Plasmodium vivax: Facts and New Approaches
Wiscovitch-Russo, R. A., Narganes-Storde, Y. M., Cano, R. J., & Toranzos, G. A. (2019) · International Microbiology · doi:10.1007/s10123-018-00053-1 · Cited by 10
Lettow, I., Berres, M., Schmitz, P., Müller, T., Berg, T., Neumann, U. P., Trautwein, C., & Wasmuth, H. E. (2010) · Human Immunology · doi:10.1016/j.humimm.2010.12.002 · Cited by 10
Molecular testing in transfusion medicine
Wagner, F. F. (2010) · Expert Opinion on Medical Diagnostics · doi:10.1517/17530059.2010.506509 · Cited by 11
“a mutation in a GATA motif of the promoter [21], or in enhancer regions as exemplified in some weak B antigens [22].”
BackgroundOsgood, J. A., & Knight, J. C. (2018) · Briefings in Functional Genomics · doi:10.1093/bfgp/ely015 · Cited by 19
“gene expression can be of small magnitude or substantial, as seen with loss of GATA-1 binding associated with a single-nucleotide change in the DARC promoter in Duffy blood group antigen-negative individuals [73].”
BackgroundSullivan, J. C., Gleadall, N., & Lane, W. J. (2022) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2022.09.016 · Cited by 10
Duffy blood group genotypes among African-Brazilian communities of the Amazon region.
Perna, S., Cardoso, G. L., & Guerreiro, J. F. (2007) · PubMed · Cited by 10
Dual role for atypical chemokine receptor 1 in myeloid cell hematopoiesis and distribution
Permanyer, M., Bošnjak, B., & Förster, R. (2017) · Cellular and Molecular Immunology · doi:10.1038/cmi.2017.79 · Cited by 10
Tung, J., Fedrigo, O. D., Haygood, R., Mukherjee, S., & Wray, G. A. (2009) · Molecular Biology and Evolution · doi:10.1093/molbev/msp113 · Cited by 13
Kappler‐Gratias, S., Peyrard, T., Rouger, P., Pennec, P. Y. L., & Pham, B.-N. (2010) · Transfusion Clinique et Biologique · doi:10.1016/j.tracli.2010.05.007 · Cited by 10
Yamakawa, R. H., Saito, P. K., da Silva, W. V., de Mattos, L. C., & Borelli, S. D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0084456 · Cited by 10
“C of the allele FY*Bpromotor region, featuring the absence of Fy antigen expression solely in erythrocytes and with no changes in the expression of this protein in other tissues [11,14,15].”
The association of pre-eclampsia with the Duffy negative phenotype in women of West African descent
Velzing‐Aarts, F. V., van der Dijs, F. P. L., Muskiet, F. A. J., & Duits, A. J. (2002) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1016/s1470-0328(02)01181-3 · Cited by 10
Single-cell transcriptomics reveals inter-ethnic variation in immune response to Falciparum malaria
Shahin, T., Jurkovic, J., Dieng, M. M., Vinu, M., Abdrabou, W. S., Alamad, B., Bayaraa, O., Diawara, A., Sermé, S. S., Henry, N. B., et al. (2025) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2025.01.020 · Cited by 11
Ness, P. M., Moulds, J. M., & Sloan, S. R. (2010) · Springer eBooks · doi:10.1007/978-1-4419-7512-6 · Cited by 9
Davis, M. B., & Newman, L. A. (2021) · Current Breast Cancer Reports · doi:10.1007/s12609-021-00426-y · Cited by 9
Vivax malaria and Duffy antigen: Stop being so negative
Duffy, P. E., Gunalan, K., & Miller, L. H. (2023) · Cell Host & Microbe · doi:10.1016/j.chom.2023.11.017 · Cited by 9
Emerging concepts in the molecular cell biology and functions of mammalian erythrocytes
Kumar, S. D., Ghosh, J., Ghosh, S., & Eswarappa, S. M. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.108331 · Cited by 13
“This mutation completely abolishes the expression of DARC in erythroid cells in homozygous individuals and partially in heterozygous individuals (108, 109).”
Genome-wide data from the Bubi of Bioko Island clarifies the Atlantic fringe of the Bantu dispersal
Gelabert, P., Ferrando-Bernal, M., de-Dios, T., Mattorre, B., Campoy, E., Gorostiza, A., Patin, É., González‐Martín, A., & Lalueza‐Fox, C. (2019) · BMC Genomics · doi:10.1186/s12864-019-5529-0 · Cited by 9
Blood groups and their function
Reid, M. E., & Yahalom, V. (2000) · Best Practice & Research Clinical Haematology · doi:10.1053/beha.2000.0096 · Cited by 9
Analysis of recombinant Duffy protein-linked N-glycans using lectins and glycosidases.
Grodecka, M., Czerwiński, M., Duk, M., Lisowska, E., & Waśniowska, K. (2010) · Acta Biochimica Polonica · doi:10.18388/abp.2010_2371 · Cited by 9
“However, Duffy expression is retained on non-erythroid tissues, suggesting the importance of this antigen (Peiper et al., 1995; Tournamille et al., 1995).”
BackgroundCowie, P., Ross, R. A., & MacKenzie, A. (2013) · Biology · doi:10.3390/biology2010064 · Cited by 10
“human receptor important for the reception of immune system signals [26 28], abolishes expression of the receptor in erythrocytes [29,30].”
BackgroundGrogan, K. E., & Perry, G. H. (2020) · Evolutionary Anthropology Issues News and Reviews · doi:10.1002/evan.21825 · Cited by 9
“disrupts the binding of transcription factor GATA1 resulting in a 20-fold decrease in expression of reporter genes in vitro.(104)”
BackgroundBlood group polymorphisms: molecular approach and biological significance
Daniels, G. L. (1997) · Transfusion Clinique et Biologique · doi:10.1016/s1246-7820(97)80043-2 · Cited by 9
The Year in Human and Medical Genetics: Highlights of 2007–2008
Smith, M. (2008) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2008.03608.x · Cited by 9
Kim, C. L. V., Tournamille, C., Kroviarski, Y., Cartron, J., & Colin, Y. (1997) · Blood · doi:10.1182/blood.v90.7.2851 · Cited by 9
Self-citationMolecular Basis of Red Cell Protein Antigen Deficiencies
Cartron, J. (2000) · Vox Sanguinis · doi:10.1111/j.1423-0410.2000.tb00029.x · Cited by 9
Self-citationEcological complexity of zoonotic malaria in macaque natural hosts
Putaporntip, C., Yanmanee, S., Somkuna, J., Rojrung, R., Pattanawong, U., Karapan, S., Kuamsab, N., Cheng, C. W., & Jongwutiwes, S. (2025) · Scientific Reports · doi:10.1038/s41598-025-86415-y · Cited by 9
Duffy antigen receptor for chemokines (DARC) and susceptibility to Plasmodium vivax malaria
Kaur, H., Sehgal, R., & Rani, S. (2019) · Parasitology International · doi:10.1016/j.parint.2019.03.013 · Cited by 8
Chemokines in transplantation: what can atypical receptors teach us about anti-inflammatory therapy?
O’Boyle, G., Ali, S., & Kirby, J. A. (2011) · Transplantation Reviews · doi:10.1016/j.trre.2010.10.005 · Cited by 8
“The polymorphism responsible for this phenotype is present in a GATA motif of the Duffy protomer [36] and prevents specifically erythrocyte expression of DARC [18]; endothelial cells from Duffy-negative individuals still express DARC [22].”
BackgroundParasol, N., Cohen, N., Zemishlany, Z., Lerer, B., & Kosower, N. S. (2001) · Human Biology · doi:10.1353/hub.2001.0024 · Cited by 8
“FY*BGATA- is not expressed in erythroid cells, due to transcriptional silencing of the erythroid FY*B allele (Tournamille et al. 1995; Iwamoto et al. 1996), but it is expressed in the other cells (Hadley and Peiper 1997).”
BackgroundInfluentialNew technologies in immunohaematology.
Morelati, F., Barcellini, W., Manera, M. C., Paccapelo, C., Revelli, N., Villa, M. A., & Marconi, M. (2007) · PubMed Central · doi:10.2450/2007.0006-07 · Cited by 8
Genotyping of Kell, Duffy, Kidd and RHD in patients with beta Thalassemia
Castilho, L. M., Rios, M., Pellegrino, J., Jr., Carvalho, M. H., Alberto, F., Saad, S. T. O., & Costa, F. F. (2000) · Revista Brasileira de Hematologia e Hemoterapia · doi:10.1590/s1516-84842000000200003 · Cited by 8
Cotorruelo, C., Fiori, S. V., Borrás, S. E. G., Racca, L., Biondi, C. S., & Racca, A. L. (2008) · BMC Medical Genetics · doi:10.1186/1471-2350-9-40 · Cited by 8
“This finding has implications for the management of transfusion therapy in this population because such patients express normal levels of the FY*B product in tissues other than red blood cells [19,20].”
BackgroundEroding the resistance of Duffy negativity to invasion by Plasmodium vivax?
Pasvol, G. (2007) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/j.trstmh.2007.05.007 · Cited by 8
Les technologies de biologie moléculaire en immunohématologie
Tournamille, C. (2013) · Transfusion Clinique et Biologique · doi:10.1016/j.tracli.2013.02.012 · Cited by 10
Self-citationThe Enigma of Plasmodium vivax Malaria and Erythrocyte Duffy Negativity
Zimmerman, P. A. (2004) · Cambridge University Press eBooks · doi:10.1017/cbo9780511546259.007 · Cited by 8
Ararat‐Sarria, M., Patarroyo, M. A., & Curtidor, H. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2018.00454 · Cited by 9
“Fy (ab) antigen results from mutations in the FYb allele promoter site thereby hampering globin transcription factor 1 (GATA1) binding (Miller et al., 1976; Tournamille et al., 1995; Daniels, 2005).”
BackgroundAldarweesh, F. A. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.89952 · Cited by 8
J. B. S. Haldane and the Malaria Hypothesis
Weatherall, J. D. (2004) · Cambridge University Press eBooks · doi:10.1017/cbo9780511546259.003 · Cited by 10
Metadata
- Authors
- Tournamille, C., Colin, Y., Cartron, J. P., & Le Van Kim, C.
- Affiliations
- Inserm (FR)
- Venue
- Nature Genetics
- Published
- 1995-06
- Volume
- 10
- Issue
- 2
- Pages
- 224-228
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2080491517
- Cited by
- 741
- References
- 32
- Citations by year
- 2026: 15 · 2025: 14 · 2024: 23 · 2023: 28 · 2022: 20 · 2021: 28 · 2020: 27 · 2019: 23 · 2018: 22 · 2017: 27 · 2016: 21 · 2015: 22 · 2014: 25 · 2013: 33 · 2012: 25
- FWCI
- 20.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Health Sciences › Medicine › Hematology › Blood groups and transfusion
- Keywords
- Duffy blood group system, promoter mutations, erythroid gene expression, Plasmodium vivax, chemokine receptors, single-exon genes, African Americans
- MeSH terms
- Antigens, Protozoan, Base Sequence, Carrier Proteins, Chromosome Mapping, DNA-Binding Proteins, Duffy Blood-Group System, Erythrocytes, Genotype, Humans, Molecular Sequence Data, Mutation, Promoter Regions, Genetic, Receptors, Cell Surface, Transcription Factors, Transcription, Genetic, Tumor Cells, Cultured, Protozoan Proteins, Gene Expression, Black People, Erythroid-Specific DNA-Binding Factors, GATA1 Transcription Factor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.